Sterility testing of cell therapy products: Parallel comparison of automated methods with a CFR-compliant method

Transfusion

Volumn 46, Issue 12, 2006, Pages 2071-2082

  Khuu, Hanh M ^a   Patel, Nayana ^a   Carter, Charles S ^a   Murray, Patrick R ^a   Read, Elizabeth J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ARTICLE; AUTOMATION; BACTERIUM CONTAMINATION; BIOENGINEERING; BLOOD CULTURE; FALSE NEGATIVE RESULT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MICROORGANISM DETECTION; MONONUCLEAR CELL; PRACTICE GUIDELINE; SENSITIVITY AND SENSIBILITY;

AUTOMATION; BACTERIA; CELL CULTURE TECHNIQUES; DRUG CONTAMINATION; FALSE POSITIVE REACTIONS; HUMANS; SENSITIVITY AND SPECIFICITY; STERILIZATION; TISSUE THERAPY;

EID: 33751378734     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.01041.x     Document Type: Article

References (37)

1. Food and Drugs. 21 C.F.R. Part 1271, Subpart A (General Provisions) (2001).
2. Food and Drugs. 21 C.F.R. Part 1271, Subpart D (Current Good Tissue Practice) (2004).
3. Standards for Cellular Therapy Product Services. 1st ed. Bethesda: American Association of Blood Banks; 2004.
4. Food and Drugs. 21 CFR Sect. 610.12 (2002).
5. USP 29 〈71〉 Sterility Tests. Rockville (MD): US Pharmacopeia; 2005.
6. Davis-Sproul J. ISCT sterility testing survey. ISCT Telegraft Newsletter 2002;9:1-3.
7. Khuu HM, Stock F, McGann M, et al. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. Cytotherapy 2004;6:183-95.
8. Wong ECC, Lee SM, Hines H, et al. Development of a closed system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers. Cytotherapy 2002;4:65-76.
9. Read EJ, Lee J, Harlan DM. Isolation of pancreatic islets for transplantation in type I diabetes. In: Sacher RA, editor. Cellular Therapy: New Frontiers in Transfusion Medicine. Bethesda: American Association of Blood Banks; 2002.
10. Reported contamination of heparin sodium with Pseudomonas putida. MMWR Morb Mortal Wkly Rep 1986;35:123-4.
11. Rowley SD, Davis J, Dick J, et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Transfusion 1988;28:109-12.
12. Stroncek DF, Fautsch DK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:512-26.
13. Lazarus HM, Magalhaes-Silverman M, Fox RM, et al. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant 1991;7:241-6.
14. Schepers KG, Davis JM, Rowley SD. Incidence of bacterial contamination of bone marrow grafts. Adv Bone Marrow Purg Process 1992:379-84.
15. Schwella N, Zimmermann R, Heuft HG, et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 1994;67:32-5.
16. Prince HM, Page SR, Keating A, et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995;15:87-91.
17. Padley D, Koontz F, Trigg ME, et al. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996;36:53-9.
18. Smith D, Bradley SJ, Scott GM. Bacterial contamination of autologous bone marrow during processing. J Hosp Infect 1996;33:71-6.
19. Attarian H, Bensigner WI, Buckner CD, et al. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 1996;17:699-702.
20. Webb IJ, Coral FS, Andersen JW, et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996;36:782-8.
21. Espinosa MTF, Fox R, Creger RJ, et al. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion 1996;36:789-93.
22. Fountain D, Ralston M, Higgins N, et al. Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion 1997;37:585-91.
23. Nasser RM, Hajjar I, Sandhaus LM, et al. Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review. Clin Infect Dis 1998;27:886-8.
24. Khuu HM, Cowley H, David-Ocampo V, et al. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. Cytotherapy 2002;4:539-49.
25. Stiegler G, Gerhartl K, Jurko S, et al. Letter to the editor. Ice from an ice machine is a potential source of bacterial contamination for HPC products - implications for cell-processing facilities. Cytotherapy 2003;5:346-7.
26. Lowder JN, Whelton P. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. Cytotherapy 2003;5:377-90.
27. Padley DJ, Greiner CW, Heddlesten-Rediske TL, et al. Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy. Cytotherapy 2003;5:147-52.
28. Kamble R, Pant S, Selby GB, et al. Microbial contamination of hematopoietic progenitor cell grafts - incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion 2005;45:874-8.
29. Munksgaard L, Albjerg L, Lellevang ST, et al. Detection of bacterial contamination of platelet components: six years' experience with the BacT/ALERT system. Transfusion 2004;44:1166-73.
30. Hundhausen T, Muller TH; GERMS Group. False-positive alarms for bacterial screening of platelet concentrates with BacT/ALERT new-generation plastic bottles: a multicenter pilot study. Transfusion 2005;45:1267-74.
31. Brecher ME, Hay SN, Rothenberg SJ. Evaluation of a new generation of plastic culture bottles with an automated microbial detection system for nine common contaminating organisms found in PLT components. Transfusion 2004;44:359-63.
32. Brecher ME, Hay SN, Rothenberg SJ. Validation of BacT/ALERT plastic culture bottles for use in testing of whole blood-derived leukoreduced platelet-rich-plasma-derived platelets. Transfusion 2004;44:1174-8.
33. Brecher ME, Means N, Jere CS, et al. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion 2001;41:477-82.
34. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005;45:1845-52.
35. Kielpinski G, Prinzi S, Duguid J, et al. Roadmap to approval: use of an automated sterility test method as a lost release test for Carticel, autologous cultured chondrocytes. Cytotherapy 2005;7:531-41.
36. Read EJ, Nambiar A, Trischmann T, et al. Enrichment of peripheral blood monocytes for dendritic cell immunotherapy using the Elutra® cell separation system [abstract]. Cytotherapy 2004;6:437.
37. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005;18:195-204.